AI assistant
Sending…
Medivir — Major Shareholding Notification 2016
May 23, 2016
3177_iss_2016-05-23_3365e3d9-2637-4772-a2c6-b620dd90db51.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Medivir Aktiebolag
Holder
Nordea Funds Oy
Instrument
| Instrument | B SE0000273294 | |
|---|---|---|
| Before the transaction | ||
| Shares | 1,502,751 | |
| Voting rights | 1,502,751 | |
| Transaction | ||
| Reason for major shareholding notification Buy | ||
| Date | 19/05/2016 | |
| Limit for number of votes | 5 % | |
| After the transaction | ||
| Quantity | ||
| Shares | 1,707,775 | |
| Directly held voting rights | 1,707,775 | |
| Indirectly held voting rights | 0 | |
| Percentage | ||
| Directly held shares | 6.333 % | |
| Directly held voting rights | 5.267 % | |
| Indirectly held voting rights | 0 % | |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 5.267 % | 1,707,775 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled - Cash settled |
||
| Total | 5.267 % | 1,707,775 |
| Group total holdings Voting rights 1,707,775 Percentage of voting rights 5.267 |
||
| Published 23/05/2016 12:20 Contact Name Maiken Lesemann Phone 004555472020 |
Email [email protected] |
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Medivir
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 21
AGM Information
2026
May 7
AGM Information
2026
May 7
Interim / Quarterly Report
2026
May 5
Interim / Quarterly Report
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 8
Proxy Solicitation & Information Statement
2026
Apr 8
Annual Report
2026
Apr 1
Major Shareholding Notification
2026
Mar 2